Jadwal Sholat

Memuat jadwal sholat…

Kedokteran & Kesehatan editorial

Open AccessOA2023

Molecular Hydrogen Therapy—A Review on Clinical Studies and Outcomes

This review assesses 81 clinical trials and 64 human studies on hydrogen therapy, finding positive indications across cardiovascular, cancer, respiratory, and neurological disorders. It also discusses administration challenges and future directions.
Hennie Marie Johnsen; Marianne Hiorth; J. Klaveness· Molecules· 2023· DOI 10.3390/molecules28237785

The core problem

Hydrogen gas (H₂) has emerged as a potential therapeutic agent due to its antioxidant properties. With over 2000 publications and numerous clinical trials registered, research spans in vitro, animal, and human studies. This review aims to evaluate the current evidence from 81 clinical trials and 64 human studies, covering major disease areas such as cardiovascular diseases, cancer, respiratory diseases, central nervous system disorders, and infections. The introduction sets the stage for discussing administration methods, challenges like hydrogen's explosive hazards and low solubility, and future technologies to overcome these issues. The overarching questions are whether hydrogen gas will become a new drug substance in clinical practice, and if so, what form and indications it might take.

Innovation

The authors conducted a comprehensive search of medical databases using the term "hydrogen gas," yielding over 2000 publications. They also searched clinical trial registers, identifying 81 clinical trials and 64 scientific publications on human studies. The review focuses on these human studies to assess therapeutic outcomes. The methodology includes an analysis of administration methods, such as inhalation, oral ingestion of hydrogen-rich water, and injection of hydrogen-saline. Challenges related to hydrogen's physicochemical properties, including its explosive nature and low solubility, are examined. The review also explores innovative technologies to mitigate these challenges, such as using hydrogen-generating materials or encapsulation techniques.
Introduction
Hydrogen gas (H₂) has emerged as a potential therapeutic agent due to its antioxidant properties. With over 2000 publications and numerous clinical trials registered, research spans in vitro, animal, and human studies. This review aims to evaluate the current evidence from 81 clinical trials and 64 human studies, covering major disease areas such as cardiovascular diseases, cancer, respiratory diseases, central nervous system disorders, and infections. The introduction sets the stage for discussing administration methods, challenges like hydrogen's explosive hazards and low solubility, and future technologies to overcome these issues. The overarching questions are whether hydrogen gas will become a new drug substance in clinical practice, and if so, what form and indications it might take.

Why it matters

The discussion elaborates on the findings, addressing the potential of hydrogen as a new drug substance. The authors note that while the results are promising, many studies are small and lack standardization. The administration form remains a key question: inhalation offers rapid absorption but requires careful handling due to explosion risks; oral hydrogen-rich water is convenient but has low bioavailability; injection provides precise dosing but is invasive. The clinical indications are broad, but further large-scale, randomized controlled trials are needed to confirm efficacy. The review also highlights the need for innovative technologies to improve hydrogen delivery, such as using porous materials or chemical carriers. Overall, hydrogen therapy holds promise but requires more rigorous research before widespread clinical adoption.

Who should read this

Pembaca Research Digest dan praktisi rumpun ini.

Opening member content…